A framework for identification of infections that contribute to human obesity

The Lancet Infectious Diseases

Volumn 11, Issue 12, 2011, Pages 963-969

  Dhurandhar, Nikhil V ^a  

^a Louisiana State University System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 36; INFECTION; NOTE; OBESITY; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ANIMALS; HUMANS; INFECTION; LONGITUDINAL STUDIES; OBESITY; PHENOTYPE;

EID: 81855185355     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70274-2     Document Type: Note

References (56)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 984:1-253. WHO, I-XII.
2. McAllister EJ, Dhurandhar NV, Keith SW, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009, 49:868-913.
3. Fact sheet on overweight and obesity WHO, (accessed Nov 2, 2011). http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/.
4. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB A virally induced obesity syndrome in mice. Science 1982, 216:82-85.
5. Pasarica M, Dhurandhar NV Infectobesity: obesity of infectious origin. Adv Food Nutr Res 2007, 52:61-102.
6. Bernard A, Cohen R, Khuth ST, et al. Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus. J Virol 1999, 73:7317-7327.
7. Bernard A, Zwingelstein G, Meister R, Wild TF Hyperinsulinemia induced by canine distemper virus infection of mice and its correlation with the appearance of obesity. Comp Biochem Physiol B 1988, 91:691-696.
8. Carter JK, Smith RE Specificity of avian leukosis virus-induced hyperlipidemia. J Virol 1984, 50:301-308.
9. Carter JK, Smith RE Rapid induction of hypothyroidism by an avian leukosis virus. Infect Immun 1983, 40:795-805.
10. Carter JK, Ow CL, Smith RE Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun 1983, 39:410-422.
11. Gosztonyi G, Ludwig H Borna disease-neuropathology and pathogenesis. Curr Top Microbiol Immunol 1995, 190:39-73.
12. Pattison IH, Jones KM Modification of a strain of mouse-adapted scrapie by passage through rats. Res Vet Sci 1968, 9:408-410.
13. Dhurandhar N, Kulkarni P, Ajinkya S, Sherikar A Avian adenovirus leading to pathognomonic obesity in chicken. J Bom Vet College 1990, 2:131-132.
14. Dhurandhar NV, Kulkarni P, Ajinkya SM, Sherikar A Effect of adenovirus infection on adiposity in chicken. Vet Microbiol 1992, 31:101-107.
15. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000, 24:989-996.
16. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 2001, 25:990-996.
17. Dhurandhar NV, Whigham LD, Abbott DH, et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 2002, 132:3155-3160.
18. Pasarica M, Shin AC, Yu M, et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006, 14:1905-1913.
19. Whigham LD, Israel BA, Atkinson RL Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 2006, 290:R190-R194.
20. So PW, Herlihy AH, Bell JD Adiposity induced by adenovirus 5 inoculation. Int J Obes Relat Metab Disord 2005, 29:603-606.
21. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004, 101:15718-15723.
22. Schilder RJ, Marden JH Metabolic syndrome and obesity in an insect. Proc Natl Acad Sci USA 2006, 103:18805-18809.
23. McFerran JB, Adair B, Connor TJ Adenoviral antigens (CELO, QBV, GAL). Am J Vet Res 1975, 36:527-529.
24. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL Association of adenovirus infection with human obesity. Obes Res 1997, 5:464-469.
25. Foy HM, Grayston JT Viral infections of humans: epidemiology and control. Adenoviruses 1976, 53-70. Plenum Medical, New York. A.S. Evans (Ed.).
26. Horvath J, Palkonyay L, Weber J Group C adenovirus DNA sequences in human lymphoid cells. J Virol 1986, 59:189-192.
27. Wigand R, Gelderblom H, Wadell G New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol 1980, 64:225-233.
28. Pasarica M, Mashtalir N, McAllister EJ, et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008, 26:969-978.
29. Salehian B, Forman SJ, Kandeel FR, Bruner DE, He J, Atkinson RL Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity. Emerg Infect Dis 2010, 16:850-852.
30. Atkinson RL, Dhurandhar NV, Allison DB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005, 29:281-286.
31. Trovato GM, Castro A, Tonzuso A, et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009, 33:1402-1409.
32. Goossens VJ, deJager SA, Grauls GE, et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) 2011, 19:220-221.
33. Broderick MP, Hansen CJ, Irvine M, et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond) 2010, 34:302-308.
34. Trovato GM, Martines GF, Garozzo A, et al. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010, 30:184-190.
35. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2010, 34:89-93.
36. Atkinson RL, Lee I, Shin HJ, He J Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 2009, 10:1-4.
37. Gabbert C, Donohue M, Arnold J, Schwimmer JB Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010, 126:721-726.
38. Gosztonyi G, Kao M, Bode L, Ludwig H Obesity syndrome in experimental infection of rats with Borna disease virus. Clin Neuropathol 1991, 10:33-34.
39. Chen CH, Chiu YL, Wei FC, et al. High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan. Mol Psychiatry 1999, 4:33-38.
40. Ferszt R, Severus E, Bode L, et al. Activated Borna disease virus in affective disorders. Pharmacopsychiatry 1999, 32:93-98.
41. Faith MS, Butryn M, Wadden TA, Fabricatore A, Nguyen AM, Heymsfield SB Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev 2011, 12:e438-e453.
42. Rathod M, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity (Silver Spring) 2009, 17:657-664.
43. Vangipuram SD, Yu M, Tian J, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007, 31:87-96.
44. Rogers PM, Mashtalir N, Rathod MA, et al. Metabolically favorable remodeling of human adipose tissue by human adenovirus Ad-36. Diabetes 2008, 57:2321-2331.
45. Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond) 2007, 31:78-86.
46. Krishnapuram R, Dhurandhar EJ, Dubuisson O, et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011, 300:e779-e789.
47. Dart AM, Martin JL, Kay S Association between past infection with Chlamydia Pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes Relat Metab Disord 2002, 26:464-468.
48. Goodson JM, Groppo D, Halem S, Carpino E Is obesity an oral bacterial disease?. J Dent Res 2009, 88:519-523.
49. Arslan E, Atilgan H, Yavasoglu I The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 2009, 20:695-697.
50. Ley RE, Turnbaugh PJ, Klein S, Gordon JI Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
51. Fernandez-Real JM, Ferri MJ, Vendrell J, Ricart W Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) 2007, 15:245-252.
52. Falagas ME, Kompoti M Obesity and infection. Lancet Infect Dis 2006, 6:438-446.
53. Cousin B, Munoz O, Andre M, et al. A role for preadipocytes as macrophage-like cells. FASEB J 1999, 13:305-312.
54. Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003, 278:9850-9855.
55. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.
56. Polk DB, Peek RM Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010, 10:403-414.